For our digital health venture capital investments through Philips Health Technology Ventures, we intentionally avoid any strategic terms (e.g. acquisition rights or distribution rights). Our desired terms are designed to mirror financial investors, with straightforward investor rights and protections in place to allow us to manage the investments.
The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.